| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/12/2008 | US7410787 Diagnosis of Whipple's disease |
| 08/12/2008 | US7410781 Nucleotide sequences coding multimeric protein for use as tool in prevention and treatment of respiratory and allergic disorders |
| 08/12/2008 | US7410780 IL-21 antagonists |
| 08/12/2008 | US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 08/12/2008 | US7410778 Expression vector comprising nucleotide sequences coding membrane receptor for use in identifying modulator for prevention and treatment of metabolic disorders; hormone replacement therapy |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/12/2008 | US7410776 Novel ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; use treating HIV infection, cancer, and various other diseases and disorders |
| 08/12/2008 | US7410774 Compounds modulating sister chromatid separation and method for identifying same |
| 08/12/2008 | US7410764 Anticancer agents, antitumor agents; monitoring mutant oncogens; signal amplification |
| 08/12/2008 | US7410758 Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN |
| 08/12/2008 | US7410757 Expressing nucleic acid in tissue from occipital cortex of brain showing cell death as result of Alzheimer's Disease; isolating suppressor gene |
| 08/12/2008 | US7410648 Nucleotide sequences coding outer memebrane proteins for use as tools in diagnosis, prevention and treatment of microorganismal infection; immunotherapy; vaccine development |
| 08/12/2008 | US7410647 Vaccines |
| 08/12/2008 | US7410646 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| 08/12/2008 | US7410645 Moraxella (Branhamella) catarrhalis antigens |
| 08/12/2008 | US7410644 Recombinant pox virus for immunization against tumor-associated antigens |
| 08/12/2008 | US7410643 Materials and methods relating to fusion proteins for inducing an immune response |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410640 Treating hypoxia driven angiogenesis or neovascularization; group B beta hemolytic Streptococcus (GBS) |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 08/12/2008 | US7410638 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| 08/12/2008 | US7410637 Transgenic algae for delivering antigens to an animal |
| 08/12/2008 | CA2354845C Expression system for factor viii |
| 08/12/2008 | CA2330235C Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 08/12/2008 | CA2302534C Organic cation transporter genes |
| 08/12/2008 | CA2253238C Novel agouti-related gene |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |
| 08/09/2008 | CA2575000A1 Synthetic hiv-1 and hiv-2 envelope genes that lead to optimized expression in bacteria for use in hiv antibody immunoassays |
| 08/07/2008 | WO2008095168A2 Compositions and methods related to a recombinant adenoviral vector that targets il 13 receptors |
| 08/07/2008 | WO2008094538A2 Regulatory t cell epitopes, compositions and uses thereof |
| 08/07/2008 | WO2008094012A1 Novel polypeptide having anti-tumor activity |
| 08/07/2008 | WO2008093756A1 Biological preparation |
| 08/07/2008 | WO2008093688A1 CHIMERIC Fcγ RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 08/07/2008 | WO2008093646A1 Peptide capable of activating wnt signaling |
| 08/07/2008 | WO2008093331A1 Antibody conjugates for circumventing multi-drug resistance |
| 08/07/2008 | WO2008093059A1 Basic peptides and their use as combined antibacterial-antifungine agents |
| 08/07/2008 | WO2008093058A2 Peptides and their use |
| 08/07/2008 | WO2008092992A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens |
| 08/07/2008 | WO2008092902A1 Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen |
| 08/07/2008 | WO2008092854A2 Papillomavirus e2 polypeptide used for vaccination |
| 08/07/2008 | WO2008092481A1 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases |
| 08/07/2008 | WO2008092450A1 Isolation and separation of minimally denatured potato proteins and peptides |
| 08/07/2008 | WO2008092262A1 Methods and compounds for treatment, prevention and diagnosis of parasitic infection and disease |
| 08/07/2008 | WO2008062457A8 Antidiabetic compounds |
| 08/07/2008 | WO2008055210A3 Sulfonylurea receptor short forms from mitochondria and uses thereof |
| 08/07/2008 | WO2008054635A3 Proteins for use in diagnosing and treating infection and disease |
| 08/07/2008 | WO2008036138A3 Methods of identifying insect-specific spider toxin mimics |
| 08/07/2008 | WO2008033555A3 High-pressure refolding of difficult-to-fold proteins |
| 08/07/2008 | WO2008021160A3 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 08/07/2008 | WO2008012045A8 Regulation of interleukin-23 |
| 08/07/2008 | WO2007149000A3 New structural protein preparations |
| 08/07/2008 | WO2007136865A3 Recombinant vectors |
| 08/07/2008 | WO2007136838A3 Methods and compositions related to gaba receptor subunits |
| 08/07/2008 | WO2007081447A8 Norovirus and sapovirus antigens |
| 08/07/2008 | WO2007079052A3 Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions |
| 08/07/2008 | US20080189809 Using vector transformation to generate transgenic plants which express brevipedicellus gene and demonstate modified floral patterning |
| 08/07/2008 | US20080189807 Nitrogen Transport Metabolism |
| 08/07/2008 | US20080189806 Protein kinase stress-related proteins and methods of use in plants |
| 08/07/2008 | US20080189798 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 08/07/2008 | US20080188644 Polypeptide containing metal ions stimulates skeletal growth and inhibits bone resorption; nutraceutical for preventing and treating osteoporosis and rheumatoid or osteo-arthritis |
| 08/07/2008 | US20080188643 flk-1 binding protein |
| 08/07/2008 | US20080188642 Contacting animal skin with acetic acid, extracting collage and freeze-drying; simpler, faster |
| 08/07/2008 | US20080188640 Immunodeficiency recombinant poxvirus |
| 08/07/2008 | US20080188443 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; modulators of the glucocorticoid receptor; asthma, dermatitis, inflammatory bowel disease, Alzheimer's disease, psychotic major depression |
| 08/07/2008 | US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 08/07/2008 | US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction |
| 08/07/2008 | US20080188420 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
| 08/07/2008 | US20080188419 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188418 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188414 In vivo half life; reversible pegylation using such as carbamate connector; synthesis |
| 08/07/2008 | US20080188413 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 08/07/2008 | US20080188410 Apoptosis-inducing polypeptides |
| 08/07/2008 | US20080188408 Protein and Preventive/Remedy for Neurodegenerative Diseases Such as Polyglutamine Diseases by Utilizing the Same |
| 08/07/2008 | US20080188404 Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement |
| 08/07/2008 | US20080188378 Novel variants of the PapM polypeptide of bacteria of the streptomyces genus |
| 08/07/2008 | US20080188008 Search for cancer markers by a novel screening method |
| 08/07/2008 | US20080188004 Assay for diabetes |
| 08/07/2008 | US20080187988 Using canida cell wall mannoprotein as tool in diagnosing yeast infection |
| 08/07/2008 | US20080187965 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 08/07/2008 | US20080187962 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187960 Botulinum neurotoxin fusion for use in modulation of pain reception; antinociceptive agents |
| 08/07/2008 | US20080187955 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety; cell-free |
| 08/07/2008 | US20080187940 Transformed Saccharomyces Cerevisiae and Method For Mass-Production of Lk8 Protein Using the Same |
| 08/07/2008 | US20080187935 Homo and Heterodimer Proteins of the Abcg Family, Methods For Detection and Screening Modulators Thereof |
| 08/07/2008 | US20080187933 Viral DNA fragments for use as probes in detecting viral infection |
| 08/07/2008 | US20080187931 Kit comprising mutant hemochromatosis protein specific immunoglobulin for use in diagnosis of blood disorder |
| 08/07/2008 | US20080187929 Method for determining preeclampsia risk |
| 08/07/2008 | US20080187904 Hepatitis C viral amino acid sequences comprising ruthenium chelate for use in generation of immunoglobulin for detection and prevention of viral infection; genetic vaccines; immunodiagnostics |
| 08/07/2008 | US20080187903 Hepatitis c viral non-structural polypeptides (NS5B) for use in screening efficacy of viricides; drug screening |
| 08/07/2008 | US20080187646 Increase in Yield by Reducing Gene Expression |
| 08/07/2008 | US20080187554 Solubilizing t-helper epitopes in buffer comprising succinic acid and manitol for use in immunoglobulin to prevent and treat human immunodeficiency viral infection; vaccines; immunotherapy |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |
| 08/07/2008 | US20080187541 Helicobacter pylori adhesin binding group antigen |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187520 Expression vector comprising nucleotide sequences coding cytotoxic exoenzyme fusion for use as tool in development of vaccine which prevent pseudomonal infection; genetic vaccines |